Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.

Andreas Münch, Johan Bohr, Stephan Miehlke, Cecilia Benoni, Martin Olesen, Ake Ost, Lars Strandberg, Per M Hellström, Erik Hertervig, Peter Armerding, Jiri Stehlik, Greger Lindberg, Jan Björk, Annika Lapidus, Robert Löfberg, Ole Bonderup, Sören Avnström, Martin Rössle, Karin Dilger, Ralph MuellerRoland Greinwald, Curt Tysk, Magnus Ström

Research output: Contribution to journalArticlepeer-review

51 Citations (SciVal)

Abstract

This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis.
Original languageEnglish
Pages (from-to)47-56
JournalGut
Volume65
Issue number1
DOIs
Publication statusPublished - 2016

Subject classification (UKÄ)

  • Gastroenterology and Hepatology

Fingerprint

Dive into the research topics of 'Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.'. Together they form a unique fingerprint.

Cite this